Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist
- PMID: 15994385
- DOI: 10.1183/09031936.05.00116104
Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist
Abstract
Nicotinic agonists, including 1,1-dimethyl-4-phenylpiperazinium (DMPP), have anti-inflammatory properties and in some instances smooth muscle relaxing effects. Since inflammation and airway smooth muscle contraction are two major components of asthma, the present authors investigated the effects of DMPP on airway inflammation and airway resistance in a mouse model of asthma. Mice were sensitised and challenged with ovalbumin (OVA) and treated either intraperitoneally or intranasally with DMPP. The effect of DMPP was tested on airway inflammation, airway resistance and on the increase of intracellular calcium in bronchial smooth muscle cells. DMPP given either during sensitisation, OVA challenges or throughout the protocol prevented lung inflammation and decreased the serum level of OVA specific immunoglobulin E. DMPP administration reduced the number of total cells, lymphocytes and eosinophils in the bronchoalveolar lavage (BAL) fluid. Intranasal DMPP administration was as effective as dexamethasone (DEXA) in reducing total cell count and eosinophil counts in BAL fluid. DMPP, but not DEXA, reduced tissue inflammation. Intranasal DMPP, given 10 min before the test, reduced airway responsiveness to metacholine. DMPP also reduced the increase in intracellular calcium in response to bradykinin. In conclusion, these results show that 1,1-dimethyl-4-phenylpiperazinium reduces lung inflammation and prevents airway hyperresponsiveness in the mouse model of asthma.
Similar articles
-
The anti-inflammatory effects of 1,1 dimethyl-4-phenylpiperazinium (DMPP) compared to dexamethasone in a guinea pig model of ovalbumin induced asthma.Eur Rev Med Pharmacol Sci. 2014;18(15):2228-36. Eur Rev Med Pharmacol Sci. 2014. PMID: 25070830
-
4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.Clin Exp Allergy. 2006 Mar;36(3):377-85. doi: 10.1111/j.1365-2222.2006.02445.x. Clin Exp Allergy. 2006. PMID: 16499650
-
Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma.Br J Pharmacol. 1998 Jul;124(5):857-64. doi: 10.1038/sj.bjp.0701901. Br J Pharmacol. 1998. PMID: 9692769 Free PMC article.
-
Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma.Int Arch Allergy Immunol. 2006;140(3):261-9. doi: 10.1159/000093283. Epub 2006 May 11. Int Arch Allergy Immunol. 2006. PMID: 16699287
-
Neurokinin-1 receptor mediates stress-exacerbated allergic airway inflammation and airway hyperresponsiveness in mice.Psychosom Med. 2004 Jul-Aug;66(4):564-71. doi: 10.1097/01.psy.0000132878.08780.93. Psychosom Med. 2004. PMID: 15272104
Cited by
-
Sequential expression of IGF-IB followed by active TGF-β1 induces synergistic pulmonary fibroproliferation in vivo.Am J Physiol Lung Cell Mol Physiol. 2012 Nov 1;303(9):L788-98. doi: 10.1152/ajplung.00008.2012. Epub 2012 Aug 24. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22923639 Free PMC article.
-
Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma.Can Respir J. 2015 Jul-Aug;22(4):230-4. doi: 10.1155/2015/832865. Can Respir J. 2015. PMID: 26252534 Free PMC article. Clinical Trial.
-
A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.Sci Rep. 2016 Jul 26;6:30451. doi: 10.1038/srep30451. Sci Rep. 2016. PMID: 27458083 Free PMC article.
-
The Role of the Acetylcholine System in Common Respiratory Diseases and COVID-19.Molecules. 2023 Jan 23;28(3):1139. doi: 10.3390/molecules28031139. Molecules. 2023. PMID: 36770805 Free PMC article. Review.
-
Third-Hand Exposure to E-Cigarette Vapour Induces Pulmonary Effects in Mice.Toxics. 2023 Sep 4;11(9):749. doi: 10.3390/toxics11090749. Toxics. 2023. PMID: 37755759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources